"Sharon has a unique skill set and broad experience encompassing ATMP manufacture and process development as well as CMC reg affairs. It was a pleasure and honor working with her over the past 8 years and I look forward to continuing a successful collaboration going forward."

Paolo Patri, CTO Stevenato Group (formally Global Head of CMC, Chiesi Farmaceutici)

”Sharon Longhurst has, as a board member, been an invaluable strategic support in making comprehensive Regulatory planning and CMC risk management for our pre-clinical and clinical development programs”

Agneta Edberg, Chairman Cell4Cure AB (formerly Idogen AB)